SEC Form 4 · accession 0000943819-26-000040
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter C Farrell
Director
Period of report
Aug 5, 2026
Accepted (ET)
Aug 6, 2026 · 2:29 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock | Aug 5, 2026 | S | 8,000 | $225.00 | D | 52,773 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The transaction was conducted under a Rule 10b5-1 plan adopted August 12, 2025.